SCHEMBL1743763

SCHEMBL1743763

Cc1cc(Br)nn2cc(Br)nc12

nearest known ligand 0.34

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.34
RXFP1 Q9HBX9 1/20 0.33
MAPT P10636 3/20 0.32
KDM4E B2RXH2 1/20 0.32
KMT2A Q03164 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
LMNA P02545 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
PDE10A Q9Y233 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24163472 0.86 ALDH1A1 (0.41) L3MBTL1RXFP1MAPTKDM4EKMT2A
SCHEMBL1744654 0.83 MAPT (0.32) L3MBTL1RXFP1MAPTKDM4EKMT2A
SCHEMBL19761072 0.71 L3MBTL1 (0.44) L3MBTL1RXFP1MAPTKDM4ESMN1; SMN2
SCHEMBL16439309 0.68 L3MBTL1 (0.42) L3MBTL1RXFP1MAPTKDM4ENPC1
SCHEMBL1745767 0.68 MAPT (0.35) L3MBTL1MAPTKMT2ASMN1; SMN2LMNA
SCHEMBL31599851 0.68 NPC1 (0.31) L3MBTL1MAPTKMT2ASMN1; SMN2NPC1
SCHEMBL31732188 0.68 HAVCR2 (0.33) L3MBTL1RXFP1
SCHEMBL19630162 0.68
SCHEMBL1744572 0.68 CSNK1E (0.38)
SCHEMBL16439355 0.66 L3MBTL1 (0.40) L3MBTL1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2385946-A1 DERIVATIVES OF 6-CYCLOAMINO-2,3-DI-PYRIDINYL-IMIDAZO[1,2-B]-PYRIDAZINE, PREPARATION AND TUERAPEUTIC APPLICATION THEREOF SANOFI (FR) 2011-11-16 EP disclosed
US-8040450-B2 Liquid crystal electro-optic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-10-18 US disclosed
WO-2010070238-A1 DERIVATIVES OF 6-CYCLOAMINO-2,3-DI-PYRIDINYL-IMIDAZO[1,2-B]-PYRIDAZINE, PREPARATION AND THERAPEUTIC APPLICATION THEREOF SANOFI-AVENTIS (FR) 2010-06-24 WO disclosed